These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6723647)

  • 21. Physicochemical characterization of PEG-PPG conjugated human urokinase.
    Kajihara J; Shibata K; Nakano Y; Nishimuro S; Kato K
    Biochim Biophys Acta; 1994 Mar; 1199(2):202-8. PubMed ID: 8123669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
    Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
    Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high molecular weight form of human urinary urokinase.
    Veronese FM; Largajolli R; Schiavon O; Casati P
    Farmaco Sci; 1987 May; 42(5):319-23. PubMed ID: 3609290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains.
    Harvey SR; Nayak SK; Markus G; Ouhammouch M; Hemperly JJ; Dillman RO; Doyle DJ
    Arch Biochem Biophys; 1997 Sep; 345(2):289-98. PubMed ID: 9308901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the high-affinity interaction between human plasminogen and pro-urokinase.
    Lijnen HR; Zamarron C; Collen D
    Eur J Biochem; 1985 Jul; 150(1):141-4. PubMed ID: 3926492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrinsic 33-kilodalton protein of spinach oxygen-evolving complexes: kinetic studies of folding and disulfide reduction.
    Tanaka S; Kawata Y; Wada K; Hamaguchi K
    Biochemistry; 1989 Sep; 28(18):7188-93. PubMed ID: 2684273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of molecular recognition in the S1-S2 intersubsite region of papain for catalytic-site chemistry. Change in pH-dependence characteristics and generation of an inverse solvent kinetic isotope effect by introduction of a P1-P2 amide bond into a two-protonic-state reactivity probe.
    Brocklehurst K; Kowlessur D; Patel G; Templeton W; Quigley K; Thomas EW; Wharton CW; Willenbrock F; Szawelski RJ
    Biochem J; 1988 Mar; 250(3):761-72. PubMed ID: 2839145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the forces which stabilize the active conformation of urokinase-type plasminogen activator.
    Sun Z; Liu BF; Chen Y; Gurewich V; Zhu D; Liu JN
    Biochemistry; 1998 Mar; 37(9):2935-40. PubMed ID: 9485445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monomer-dimer equilibria of a Bence Jones protein and its variable fragment.
    Azuma T; Kobayashi O; Goto Y; Hamaguchi K
    J Biochem; 1978 May; 83(5):1485-92. PubMed ID: 26679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The thiolase reaction mechanism: the importance of Asn316 and His348 for stabilizing the enolate intermediate of the Claisen condensation.
    Meriläinen G; Poikela V; Kursula P; Wierenga RK
    Biochemistry; 2009 Nov; 48(46):11011-25. PubMed ID: 19842716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esterolytic antibodies as mechanistic and structural models of hydrolases-a quantitative analysis.
    Lindner AB; Kim SH; Schindler DG; Eshhar Z; Tawfik DS
    J Mol Biol; 2002 Jul; 320(3):559-72. PubMed ID: 12096909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pH dependence of the binding of pro-urokinase to fibrin/celite.
    Pannell R; Angles-Cano E; Gurewich V
    Thromb Haemost; 1990 Dec; 64(4):556-8. PubMed ID: 2128139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of peptide enzymes (pepzymes): surface-simulation synthetic peptides that mimic the chymotrypsin and trypsin active sites exhibit the activity and specificity of the respective enzyme.
    Atassi MZ; Manshouri T
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8282-6. PubMed ID: 8367494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
    Vassalli JD; Baccino D; Belin D
    J Cell Biol; 1985 Jan; 100(1):86-92. PubMed ID: 3880760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label.
    Bertoldi M; Dominici P; Moore PS; Maras B; Voltattorni CB
    Biochemistry; 1998 May; 37(18):6552-61. PubMed ID: 9572873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.